These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9592567)
21. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B. Singh J; Rimek D; Kappe R Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441 [TBL] [Abstract][Full Text] [Related]
22. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test. Birinci A; Saniç A; Durupinar B J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799 [TBL] [Abstract][Full Text] [Related]
23. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro]. Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206 [TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility in vitro determined by the Etest® for Candida obtained from the oral cavity of irradiated and elderly individuals. Freitas EM; Monteiro LC; Fernandes MB; Martelli Junior H; Bonan PR; Nobre SA Braz Dent J; 2015; 26(2):99-104. PubMed ID: 25831097 [TBL] [Abstract][Full Text] [Related]
25. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705 [TBL] [Abstract][Full Text] [Related]
26. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
27. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Seifert H; Aurbach U; Stefanik D; Cornely O Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977 [TBL] [Abstract][Full Text] [Related]
28. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Espinel-Ingroff A Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349 [TBL] [Abstract][Full Text] [Related]
29. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ali I; Khan FG; Suri KA; Gupta BD; Satti NK; Dutt P; Afrin F; Qazi GN; Khan IA Ann Clin Microbiol Antimicrob; 2010 Feb; 9():7. PubMed ID: 20128889 [TBL] [Abstract][Full Text] [Related]
30. New Antifungal Susceptibility Test Based on Chitin Detection by Image Cytometry. Wang Y; Andriampamonjy AN; Bailly S; Garnaud C; Maubon D; Cornet M; Aldebert D Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658964 [TBL] [Abstract][Full Text] [Related]
32. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
34. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Dagi HT; Findik D; Senkeles C; Arslan U Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756 [TBL] [Abstract][Full Text] [Related]
35. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
36. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit]. Yüksekkaya S; Fındık D; Arslan U Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168 [TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Bartizal K; Scott T; Abruzzo GK; Gill CJ; Pacholok C; Lynch L; Kropp H Antimicrob Agents Chemother; 1995 May; 39(5):1070-6. PubMed ID: 7625791 [TBL] [Abstract][Full Text] [Related]
38. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV Shokri H; Sharifzadeh A J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species. Chen M; Zhai L; Arendrup MC Med Mycol; 2015 Feb; 53(2):194-8. PubMed ID: 25605775 [TBL] [Abstract][Full Text] [Related]
40. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole. Otcenásek M J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):129-34. PubMed ID: 2170505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]